RXQ Compounding LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Aug 8, 2017
  • Last warning letter 2016
Inspections 2 2 OAI
Recalls 88 0 Class I (0%)
Warning letters 1 Latest May 19, 2016
510(k) clearances 0 None on file

RXQ Compounding LLC has 88 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to RXQ Compounding LLC, the most recent on May 19, 2016. FDA has published 3 Form 483s for RXQ Compounding LLC.

What these totals cover: FDA records filed under the name "RXQ Compounding LLC" and its spelling variant "Rxq Compounding".

Latest recall
D-1711-2019 · Class II · Jun 19, 2019
Latest inspection
Aug 8, 2017 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls88Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances0Nov 22, 2026File dated Nov 18, 2026Current
Inspections2Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

RXQ Compounding LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

RXQ Compounding LLC: FDA inspections per year

2017: 1 inspection (1 OAI), 0 warning letters, 1 recall record (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 86 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
202000000
2019000860
201800010
201711010

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

RXQ Compounding LLC FDA Warning Letters

1 warning letter on May 19, 2016.

IssuedSubjectIssuing officeClose-out letter
May 19, 2016 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

RXQ Compounding LLC Form 483s

3 Form 483s published by FDA.

DateDocumentFEI
Jun 6, 2019 · Document on fda.gov 4833011509553
Oct 25, 2017 · Document on fda.gov 4833011509553
Nov 8, 2015 · Document on fda.gov 4833011509553

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

88 recall records from Sep 25, 2017 to Jun 19, 2019. Showing the 20 most recent. View all 88 recall records

NumberClassProductDate
D-1711-2019Class IITRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1666-2019Class IIHYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1657-2019Class IIEPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West…Jun 19, 2019
D-1679-2019Class IIMETHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1662-2019Class IIGLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1713-2019Class IITURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML per Syringe, RXQ…Jun 19, 2019
D-1659-2019Class IIFENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding…Jun 19, 2019
D-1704-2019Class IISODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State…Jun 19, 2019
D-1670-2019Class IIKETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per…Jun 19, 2019
D-1698-2019Class IIPROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1690-2019Class IIONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1677-2019Class IIMETHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1674-2019Class IIMAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1699-2019Class IIPYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH…Jun 19, 2019
D-1672-2019Class IILIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street…Jun 19, 2019
D-1656-2019Class IIEPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9…Jun 19, 2019
D-1634-2019Class IIAscorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1665-2019Class IIHYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC…Jun 19, 2019
D-1675-2019Class IIMAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State…Jun 19, 2019
D-1701-2019Class IIRIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State…Jun 19, 2019

Recent FDA inspections

2 inspections from Sep 21, 2015 to Aug 8, 2017.

DateSiteProductClassificationFEI
Aug 8, 2017Albany, OHDrugsOfficial Action Indicated (OAI)3011509553
Sep 21, 2015Albany, OHDrugsOfficial Action Indicated (OAI)3011509553
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under RXQ Compounding LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 19, 2016.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3011509553Albany, OH2Aug 8, 2017

RXQ Compounding LLC and the FDA: common questions

Has RXQ Compounding LLC received an FDA warning letter?

Yes. FDA has issued 1 warning letter to RXQ Compounding LLC. The most recent is dated May 19, 2016.

Has RXQ Compounding LLC received an FDA Form 483?

FDA has published 3 Form 483s for RXQ Compounding LLC in its reading room, the most recent dated Jun 6, 2019. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect RXQ Compounding LLC?

The most recent FDA inspection on file ended Aug 8, 2017 at Albany, OH and was classified OAI. FDA has 2 inspections of RXQ Compounding LLC on file, 2 of them classified OAI (official action indicated).

Has RXQ Compounding LLC had an FDA recall?

Yes. RXQ Compounding LLC has 88 FDA recalls on record. The most recent started Jun 19, 2019.

Need more than this page shows? Ask about RXQ Compounding LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.